Introduction
Hepatocellular carcinoma (HCC) is the fourth most prevalent human malignancy and the third cause of cancer-related deaths in China. 1 In 2015, it is estimated that there are 466,100 new cases and 422,100 deaths due to this disease. 1 Although patients with HCC can be managed with a series of therapeutic methods (including surgical resection,
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li et al adjuvant chemotherapy, radiotherapy, and liver transplantation), the overall 5-year survival rate still remains poor (less than 20%). 2 Epidemiological studies have shown that chronic hepatitis B virus (HBV) infection is the predominant risk factor for the development, metastasis, and recurrence of HCC, accounting for about 80% of all HCC in China. [3] [4] [5] Thus, it is necessary to further investigate the molecular mechanisms of HBV-related HCC in order to screen novel prognostic biomarkers and develop effective therapeutic strategies.
Recently, there have studies to indicate that the abnormal expression of lncRNAs, a class of noncoding RNAs longer than 200 nt in length, is associated with the development of various cancers, including HBV-related HCC. 6, 7 For example, Zuo et al found that lncRNA AX800134 was upregulated in HBV-positive HCC compared with HBV-negative HCC. Silencing AX800134 with siRNA interference significantly suppressed the growth and invasion but enhanced spontaneous apoptosis of HBx-expressing HepG2 cells. 8 The study of Lv et al revealed that the expression of lncRNA DREH was frequently downregulated in HBV-associated HCC tissues in comparison with adjacent noncancerous hepatic tissues. Inhibition of DREH expression by HBx remarkably promoted the proliferation of HCC cells in vitro and in vivo. 9 Yang et al identified that lncRNA-HEIH was highly expressed in liver samples from patients with HBV-related HCC. The expression level of lncRNA-HEIH in HBV-related HCC was significantly associated with recurrence and was an independent prognostic factor for survival. 10 However, the mechanisms of lncRNAs in HBV-related HCC remain not fully elucidated.
Previously, emerging evidence has demonstrated that lncRNAs may function as molecular sponges for a miRNA through their miRNAs response elements (MREs) and thereby influence the translation inhibition or mRNA degradation of the transcript on the targets by the respective miRNAs, which is proposed as ceRNA hypothesis. 11 Accumulating data also indicated that this regulatory action plays important roles in HCC development. 12, 13 For example, Lv et al 14 showed that lnRNA Unigene56159 promoted the migration and invasion of HCC cells by acting as a ceRNA for miR-140-5p to de-repress the expression of Slug and induce the epithelial-mesenchymal transition (EMT). Mo et al 15 observed the upregulated LINC01287 competitively bound to miR-298 and increased the expression of its target gene STAT3 to promote EMT and invasion of HCC cells. lncRNA n335586 was also reported to promote EMT of HCC cells and then migration as well as invasion through facilitating the expression of its host gene creatine kinase, mitochondrial 1A (CKMT1A) by competitively binding miR-924. 16 lncRNA SNHG12 functioned as an oncogene to accelerate tumorigenesis and metastasis of HCC cells by sponging miR-199a/b-5p, which resulted in the high expression of MLK3 (mitogen-activated protein kinase kinase kinase 11) and activated the NF-κB pathway. 17 HCAL directly interacted with and functioned as a sponge for miR-15a, miR-196a, and miR-196b to modulate lysosomal protein transmembrane 4 beta (LAPTM4B) expression in HCC. 18 However, studies performed to investigate the ceRNA mechanisms of lncRNAs for HBV-related HCC were rare. 14, 16 The goal of this study was to identify novel lncRNAmiRNA-mRNA interaction axes for explaining the development of HBV-associated HCC by constructing a ceRNA regulatory network using sequencing data collected from a public database. Also, the prognosis performance of related lncRNAs, miRNA, and mRNAs was also validated by utilizing The Cancer Genome Atlas (TCGA) datasets. We believe that our study may provide novel prognostic biomarkers and therapeutic targets for HBV-associated HCC.
Methods
Data collection and preprocessing
Two datasets under accession numbers GSE77509 19 and GSE76903 19 were retrieved from the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/). These two datasets examined the RNA expression profiling and noncoding (miRNA) expression profiling in 20 primary tumors and 20 matched adjacent normal tissues from patients with HBV-induced HCC by high-throughput sequencing via HiSeq 2500 System (Illumina, San Diego, CA, USA). The samples were the same for the two datasets. The fragment per kilobase per million mapped reads (FPKM) expression data in TXT files were downloaded and preprocessed by removing low abundance genes with an FPKM of <1. The lncRNA and mRNA genes in RNA expression profiling were annotated based on the Ensembl Gene ID and HUGO Gene Nomenclature Committee (HGNC; http://www.genenames.org/). 20 
Differentially expressed Rna analysis
The differentially expressed genes (DEGs), differentially expressed lncRNAs (DELs), and differentially expressed miRNAs (DEMs) between primary tumors and adjacent normal tissues were identified using the EdgeR package of R software (Version 3.22.3; http://www.bioconductor.org/packages/release/bioc/html/edgeR.html).
21 P-value was adjusted to false discovery rate (FDR) with multitest package (Version 2.36.0; http://bioconductor.org/packages/release/bioc/html/ multtest.html). 22 The FDR of <0.05 and |logFC(fold change)| was used to assess the direct and indirect correlations between DEGs. The screened interaction pairs among DEGs were used to construct the PPI network with the Cytoscape software (Version 3.6.1; www.cytoscape.org/). 24 The topological features of the PPI network, consisting of degree (the number of edges [interactions] of a node protein]), betweenness centrality (BC; the number of shortest paths that run through a node), closeness centrality (CC; the average length of the shortest paths to access all other proteins in the network), and average path length (APL; the average of distances between all pairs of nodes), were then calculated using the CytoNCA plugin in cytoscape software (http://apps.cytoscape.org/apps/cytonca) 25 to determine which genes were hub nodes. Functionally related clusters with well-interconnected genes were further identified from the PPI network using the Molecular Complex Detection (MCODE; Version: 1.4.2, http://apps.cytoscape.org/apps/ mcode) algorithm 26 with default scoring options. Modules with score >4 and node >6 were considered to be significant.
Function enrichment analysis
Gene Ontology (GO) Biological Process term and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of DEGs were conducted using the Database for Annotation, Visualization and Integrated Discovery (DAVID) online tool (Version 6.8; http://david.abcc.ncifcrf. gov) 27 and BinGO 28 plugin in Cytoscape to predict their underlying functions. Statistical significance was defined as FDR <0.05.
lncRna-miRna-mRna ceRna regulatory network construction
The miRcode database (Version 11; http://www.mircode. org/) 29 was used to screen the interaction relationships between DELs and DEMs, and then, the DELs-DEMs interaction network was constructed using the Cytoscape software (Version 3.6.1; www.cytoscape.org/). 24 The target genes of DEMs in the DELs-DEMs interaction network were predicted using the miRwalk database (Version 2.0; http://www.zmf.umm. uni-heidelberg.de/apps/zmf/mirwalk2), 30 which were then overlapped with the DEGs to obtain the DELs-DEMs-DEGs regulatory relationships. The negative interaction pairs between DEMs and DEGs/DELs were integrated to construct the DELs-DEMs-DEGs ceRNA network using the Cytoscape software (Version 3.6.1; www.cytoscape.org/). 24 Furthermore, all known HCC-related pathways were downloaded from Comparative Toxicogenomics Database (CTD; http://ctd.mdibl.org/), 31 which was then overlapped with the pathways enriched by the genes in the ceRNA network to obtain potentially HCC-related ceRNA network.
Prognosis values of Dels, DeMs, and Degs in ceRna network
The miRNAs and mRNAs expression profile data of HCC were also collected from TCGA (https://gdc-portal.nci.nih. gov/) database, with only the HBV samples having survival information, included. Univariate Cox regression analysis was performed to screen prognosis-related DELs, DEMs, and DEGs using the survival package (Version 2.40.1; https://cran.r-project. org/package=survival). The samples were then classified into a low-expression group (< median) and a high-expression group (> median) based on the expression of each prognosis-related DEL, DEM, and DEG. The Kaplan-Meier (KM) method with the log-rank test was employed to compare the overall survival (OS) and recurrence-free survival (RFS) between the high-and low-expression groups through the GraphPad Prism software (Version 5; GraphPad Software, Inc., La Jolla, CA, USA). P<0.05 was considered to be statistically significant.
Validation of expressions of crucial Dels, DeMs, and Degs in ceRna network
The expressions of crucial DELs, DEMs, and DEGs were also validated in TCGA dataset and other microarray datasets that detected the mRNA (GSE121248: 70 vs 37; GSE94660 
Results
Differential expression analysis
A total of 133 lncRNAs, 18,628 protein-coding mRNAs, and 2,578 miRNAs were annotated in mRNA-seq and miRNAseq data. After removing the low abundance genes with an Table 1) . The heat map analysis showed that the samples with similar features tended to be clustered according to the expressions of DELs ( Figure 1A ), DEMs ( Figure 1B) , and DEGs ( Figure 1C ).
Function enrichment for Degs
The upregulated and downregulated DEGs were subjected to the DAVID to predict their functions. The results indicated that 16 GO biological process terms were obtained for the upregulated genes, mainly involving cell cycle (ie, E2F2, CDK1, CCNE1, BUB1, UBE2C, and CCNB1), while 27 GO biological process terms were enriched for the downregulated genes, mainly involving inflammatory response (PF4 and CXCR1) ( Table 2 and Figure 2A) . Furthermore, the KEGG pathway enrichment analysis was performed. In line with the GO enrichment results, the cell cycle (E2F2, CDK1, CCNE1, BUB1, and CCNB1) and p53 signaling pathway (CDK1, CCNE1, and CCNB1) were also obtained for the upregulated genes, while cytokine-cytokine receptor interaction was enriched for the downregulated genes (PF4 and CXCR1) ( Table 3 and Figure 2B ).
PPi network construction
Using the STRING database, 2,065 interaction relationship pairs (eg, BUB1-CDK1) were obtained between the 357 DEGs (182 downregulated and 175 upregulated), which were used for constructing a PPI network (Figure 3) . After calculating the topological features for each protein in PPI network, CCNB1, CDK1, G protein subunit gamma 4 (GNG4), UBE2C, G protein subunit gamma transducin 1 (GNGT1), kinesin family member 4A (KIF4A), PF4, and G protein subunit gamma 13 (GNG13) were found to be shared in four topological characteristics and ranked in the top 30, suggesting that they may be hub genes (Table 4) .
Four significant functionally related modules ( Figure 4 ) were subsequently screened using the MCODE, among which the module 1 was the most significant with score =14.474 and node =38, followed by module 2 with score =13.152 and node =46. Also, GO analysis of genes in modules 1 and 2 with BinGO plugin of Cytoscape indicated that they were involved in mitotic cell cycle (CCNB1, CDK1, BUB1, and UBE2C) and cell surface receptor-linked signaling pathway (PF4 and CXCR1) ( Table 5 ). 
CeRna network construction
By searching the miRcode database, 14 DELs-DEMs interaction relationship pairs (including five DELs, all upregulated, and 10 DEMs, five upregulated and five downregulated) were predicted, which were used for constructing the DELs-DEMs network. Subsequently, the target genes of these 10 DEMs were predicted with the miRwalk database. After removal of the positive-negative relationships between DEMs and DEGs, 113 DELs-DEMs interaction relationship pairs (including eight DEMs, three upregulated and five downregulated, and 82 DEGs, 67 upregulated and 15 downregulated) were left for constructing the DEMs-DEGs network. By integrating the DELs-DEMs network and DEMs-DEGs network, a DELs-DEMs-DEGs ceRNA network was established containing 95 nodes (five DELs, eight DEMs, and 82 DEGs) and 239 edges (14 DELs-DEMs, 113 DELs-DEGs, and 112 DEGs-DEGs) ( Figure 5 ). Function enrichment analysis with DAVID showed the genes in the ceRNA network participated in four significant KEGG pathways, including cell cycle, p53 signaling pathway, neuroactive ligand-receptor interaction, and pathways in cancer (Table 6 ). By searching the CTD database with "Hepatocellular Carcinoma" as the keyword, 244 KEGG pathways were found to be associated with HCC. Among them, three were common with the enrichment results of the genes in the ceRNA network, including cell cycle (CCNE1, E2F2, and CDK1), p53 signaling pathway (CCNE1 and CDK1), and pathways in cancer (E2F2). Thus, the DELs-DEMs-DEGs interaction relationship pairs associated with these three pathways were extracted to form the HCC-related ceRNA network T10  T20  T19  T12  T16  T6  T21  T18  T3  T17  T14  T11  T8  T22  T15  T24  T26  T13  N20  N16  N17  N21  N24  N14  N19  N22  N7  N26  N11  N13  N10  N6  N12  N25  N18  N15  N3  N8  T7   T8  T7  T17  T26  T15  T22  T13  T6  T19  T12  T25  T10  T18  T3  T24  T11  T21  T16  T14  N19  N15  N18  N22  N21  N14  N17  N7  N16  N11  N26  N20  N8  N13  N3  N6  N10  N12  N24  N25  T20   T19  T12  T21  T16  T8  T7  T6  T3  T18  T11  T22  T13  T24  T17  T20  T26  T25  T14  T10  N21  N18  N24  N15  N26  N20  N19  N22  N7  N6  N10  N14  N16  N12  N25  N3  N13  N8  N11  N17  T15 -2 ( Figure 6 ), in which four DELs (DSCR4, FAM182B, PRNT, and LINC00346), five DEMs (hsa-miR-199a-5p, hsa-miR-30a-5p, hsa-miR-125b-5, hsa-miR-10a-5p, and hsa-miR-133a-3p), and seven DEGs (CDC6, CCNE1, CDK1, E2F2, BUB1, CCNB1, and SFN) were involved.
Prognosis prediction for Dels, DeMs, and Degs
Ninety-eight HBV-related HCC samples, which have been used for mRNA and miRNA sequencing, were collected from TCGA database. Univariate Cox regression analysis was then used to screen OS-and RFS-related DELs, DEMs, and DEGs from HCC-related ceRNA network in these samples. The results showed that two DELs, four DEMs, and seven DEGs were significantly associated with OS, but only five DEGs were significantly associated with RFS (Table 7) . KM curve was subsequently drawn according the expression level of each DEL, DEM, and DEG in the sequencing data.
In line with the Cox regression analysis results, KM curve analysis also (Figure 7) showed that two DELs (FAM182B and LINC00346), four DEMs (hsa-miR-30a-5p, hsa-miR125b-5p, hsa-miR-10a-5p, and hsa-miR-133a-3p), and seven DEGs (CDC6, CCNE1, CDK1, E2F2, BUB1, CCNB1, and SFN) were significantly associated with OS but not PRNT (expression value =0 in TCGA data), DSCR4 (P=0.493), and hsa-miR-199a-5p (P=0.101). Also, all the relationships between their expressions and the prognosis results were in line with our expectation, that is, patients with the high expression of the DELs and DEGs (all were upregulated genes in HBV-related HCC) had the poor survival, while patients with the high expression of DEMs (all were downregulated genes in HBV-related HCC) possessed excellent survival. As shown in Figure 8 , KM curve analysis also showed that the highly expressed five DEGs (CDC6, CDK1, BUB1, CCNB1, and SFN) were significantly associated with RFS. Further combination with their interaction relationships in the ceRNA network suggested that FAM182B-miR-125b-5p-E2F2 and LINC00346-miR-10a-5p-CDK1/CCNE1 ceRNA axes were especially important for the development and prognosis of HBV-related HCC.
Validation of expressions of crucial Dels, DeMs, and Degs in ceRna network
The upregulation of LINC00346, CDK1, and CCNE1 but the downregulation of miR-10a-5p and miR-125b-5p was also validated in other microarray datasets and TCGA data. 
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lncRna-related ceRna network for hBV-hCC FAM182B was not found to be differentially expressed in GSE27462 and TCGA data. E2F2 was demonstrated to be differentially expressed in GSE94660, GSE25599, and TCGA data but not in GSE121248 (Table 8 ). These findings indicated that LINC00346-miR-10a-5p-CDK1 ceRNA axis may be a potentially verifiable mechanism for HBV-related HCC.
Discussion
In the present study, we identified FAM182B-miR-125b-5p-E2F2 and LINC00346-miR-10a-5p-CDK1/CCNE1 ceRNA axes as important mechanisms for the development of HBV-related HCC. They were involved in HBV-related HCC by influencing cell cycle. Also, the genes in these two axes were significantly associated with the OS of patients.
LINC00346-miR-10a-5p-CDK1 may be especially crucial because CDK1 was considered as a hub gene in the PPI network and was also associated with RFS as well as the expressions of all of them confirmed in other datasets.
Numerous studies have shown that HBV infection of hepatocytes promotes cell cycle progression by accelerating G1/S and G2/M transition and thus increases cell proliferation ability, ultimately inducing the development of HCC. 35, 36 It is well accepted that CCNE1 is a positive regulator of G1/S phase transition 37 and CCNB1 is required for G2/M transition and mitosis resumption by forming a maturation promoting factor with CKD1. 38 Transcriptional factor E2F2 can be activated by Cyclin-CDK enzymatic complex after phosphorylating the protein retinoblastoma (Rb), which promotes the transcription of E2F2 (Up)GO:0051726~regulation of cell cycle (Up)GO:0051327~M phase of meiotic cell cycle (Up)GO:0051321~meiotic cell cycle (Up)GO:0051301~cell division (Up)GO:0048285~organelle fission (Up)GO:0022403~cell cycle phase (Up)GO:0022402~cell cycle process (Up)GO:0010564~regulation of cell cycle process (Up)GO:0007346~regulation of mitotic cell cycle (Up)GO:0007267~cell-cell signaling (Up)GO:0007067~mitosis (Up)GO:0007049~cell cycle (Up)GO:0000280~nuclear division (Up)GO:0000279~M phase (Up)GO:0000278~mitotic cell cycle (Up)GO:0000087~M phase of mitotic cell cycle (Down)GO:0060341~regulation of cellular localization (Down)GO:0051969~regulation of transmission of nerve impulse (Down)GO:0051050~positive regulation of transport (Oown)GO:0051046~regulation of secretion (Down)GO:0050900~Ieukocyte migration (Down)GO:0050804~regulation of synaptic transmission (Down)GO:0048878~chemical homeostasis (Down)GO:0048666~neuron development (Down)GO:0044057~regulation of system process (Down)GO:0042742~defense response to bacterium (Oown)GO:0042330~taxis (Down)GO:0031644~regulation of neurological system process (Down)GO:0030182~neuron differentiation (Down)GO:0022610~biological adhesion (Down)GO:0016101~diterpenoid metabolic process (Down)GO:0009611~response to wounding (Down)GO:0007626~Iocomotory behavior (Down)GO:0007610~behavior (Down)GO:0007268~synaptic transmission (Down)GO:0007267~cell-cell signaling (Down)GO:0007155~cell adhesion (Down)GO:0006954~inflammatory response (Down)GO:0006952~defense response (Down)GO:0006935~chemotaxis (Down)GO:0006776~vitamin A metabolic process (Down)GO:0006775~fat-soluble vitamin metabolic process (Down)GO:0001523~retinoid metabolic process Cheng et al 42 also used in vitro experiments to prove HBV persistently activated the CCNB1-CDK1 kinase in HCC cells. In line with these studies, our study also found CCNE1, CCNB1, and CKD1 were upregulated in tumor samples of patients with HBV-related HCC and the high expression of them predicted poor prognosis. The CKD1 may be especially important because it was associated with both OS and RFS. Although there was a study to indicate E2F2 upregulation in HCC, 43 its relationship with HBV has not been investigated. Our study may be the first to reveal that HBV infection may trigger E2F2 upregulation and lead to the development of HCC and poor prognosis for patients. miRNAs are the class of small RNAs (18-25 nucleotides) that downregulate target gene expressions via binding to the 3′-untranslated region (UTR). Thus, the upregulation of cell cycle-related genes may be attributed to the downregulation of miRNAs. In this study, we also investigated the DEMs between tumor and normal samples and predicted their interaction with target genes by the identified the DEMs in seven paired specimens of HCC using the microarray technique and found that miR-10a-5p and miR-125b-5p were significantly downregulated. Overexpression of miR-10a 50 and miR-125b 51 was reported to suppress the metastasis of HCC cells in vivo. In line with these studies, our study also showed that miR-10a-5p and miR-125b-5p were downregulated in HBV-related HCC and high expression of them predicted excellent prognosis. lncRNAs are proposed to act as a ceRNA to involve in the regulation effects of miRNAs on the expression of target genes. Thus, the upregulation of cell cycle-related genes may also be attributed to the upregulation of lncRNAs that sponged the miRNAs. In this study, we also investigated the DELs between tumor and normal samples and predicted their interaction with miRNAs by the miRcode database. Our results indicated that upregulated FAM182B and LINC00346 may regulate cell cycle-related genes by interacting with miR-125b-5p and miR-10a-5p, resulting in poor prognosis. In line with our study, there has been a study to demonstrate that LINC00346 was upregulated miRwalk database. Our results indicated that miR-10a-5p and miR-125b-5p could regulate CDK1/CCNE1 and E2F2, respectively. There have studies to explore the miRNAs to regulate these target genes in HCC, such as miR-7/497/195-CCNE1, 44, 45 miR-582-5p-CDK1, 46 and miR-214/490-E2F2, 47, 48 but not focused on the relationships of our prediction. However, the studies on the expressions of miR-10a-5p and miR-125b-5p in HCC may indirectly Knockdown of LINC00346 inhibited bladder cancer cell proliferation and migration and induced cell cycle arrest and cell apoptosis. 52 The high expression of LINC00346 was also found to be significantly associated with poor OS in HCC 53 and breast cancer samples. 54 Nevertheless, no studies were performed to investigate the interaction of LINC00346 with miRNAs. Also, any investigation related to FAM182B has not been found until now. These implied that our identified ceRNA axes (FAM182B-miR-125b-5p-E2F2 and LINC00346-miR-10a-5p-CDK1/CCNE1) may be novel mechanisms for HBV-related HCC.
There were some limitations in this study. First, our study has preliminarily predicted that these ceRNA axes may be associated with the development of HBV-related HCC and some of them were confirmed in some other microarray datasets. Thus, further clinical, in vitro (dual luciferase reporter assay), and in vivo (loss of function) experiments are necessary to validate the expressions of controversial genes (such as FAM182B and E2F2) and regulatory relationships between DELs and DEMs as well as between DEMs and DEGs, and their roles for the proliferation, metastasis, and invasion of HBV infection hepatocytes. Second, there were no clinical data in our used datasets (GSE77509 and GSE76903) and, thus, we only preliminarily predicted the associations between prognosis (OS and RFS) and each of our identified DEL/DEM/DEG using TCGA data via univariate cox regression analysis. Whether these genes were independent biomarkers needed further clinical trials with multivariate Cox's model that integrated all the clinical information (such as HBV DNA level, liver function parameters, pathologic stage, pathologic node, and pathologic metastasis, grade, therapeutic strategies including hepatectomy, radiofrequency ablation, and solafenib) [55] [56] [57] and all DELs/DEMs/DEGs expression levels. 
Conclusion
The present study preliminarily indicates that FAM182B and LINC00346 may be novel prognostic biomarkers and therapeutic targets for HBV-associated HCC. They function as a ceRNA to sponge miR-125b-5p and miR-10a-5p to derepress cell cycle-related genes (E2F2, CDK1, and CCNE1) and promote the cell growth of HCC cells.
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